GEN Edge - Latest

Latest

All

GEN Edge

Base Editing Tweaks Mouse Gut Microbiome, in Scientific First

Drug Discovery

Lilly to Acquire Morphic for $3.2B, Adding Phase II IBD Programs

GEN Edge

Gee WIZ: Novartis’ “Glue Degrader” Drug Candidate for Sickle Cell Shows Promise in Animal Studies

OMICs

Aiming High: 10x, NanoString Launch Large-Scale Panels

Drug Discovery

FDA Approves Lilly’s Amyloid-Targeting Kisunla for Early Alzheimer’s

Artificial Intelligence

Absci Eyes Busy 2025 as Lead AI-Designed Candidate Heads for Clinic

Bioprocessing

StockWatch: Layoffs, ARK Selloff Sink Ginkgo Bioworks

GEN Edge

A Story of Perseverance: An Interview with Matthew Porteus

Infectious Diseases

GeoVax Advances COVID-19 Vaccine with Up to $45M from BARDA

Genome Editing

Come Together: Bridge RNAs Close the Gap to Genome Design

OMICs

StockWatch: “Final Resolution” Set for Illumina’s Grail Saga

Artificial Intelligence

Insilico Moves HQ to Cambridge, MA, Completes IPF Trial Enrollment

Drug Discovery

RNA Rewriting to Treat Neurological Disease Focus of Ascidian, Roche Collaboration

Drug Discovery

StockWatch: Chinese Biotechs Targeted by BIOSECURE Act Rise after House Committee Setback

Bioprocessing

“Talent, Talent, Talent” Drives Fujifilm Diosynth’s $3.2B NC Expansion

Artificial Intelligence

AlphaFold 3 Angst: Limited Accessibility Stirs Outcry from Researchers

Drug Discovery

Mussel-Inspired Polymer Helps Syntis Bio Deliver Drugs by Coating the Intestine

Drug Discovery

Alzheimer’s Drug Developer Alzheon Closes $100M Series E Financing

Artificial Intelligence

StockWatch: Nvidia’s $3T Market Cap, Tempus’ $400M IPO Reflect AI Allure

Bioprocessing

Entos Expands In-House Manufacturing with GMP Facility

Infectious Diseases

Shionogi, Qpex to Open Antimicrobial R&D Lab in San Diego

Bioprocessing

Cytiva Launches Next-Gen Cell Therapy Manufacturing Platform

Drug Discovery

StockWatch: Insmed Shares Leap 150%, as Analysts See Next Blockbuster

Artificial Intelligence

Illumina Ventures Labs Adds Sequencing to Integrated Biosciences’ “Ultimate” Drug Screening

Artificial Intelligence

Bud-wiser: DOD Backs A-Alpha Bio for Biothreat Preparation

Cancer

JAK Attack: Ajax Takes Aim at Myelofibrosis

Drug Discovery

StockWatch: Like a Bolt from the Blue, Cancer Drug Developer Nosedives

Bioprocessing

Wyss Spinout Circe Biosciences to Engineer Greenhouse Gas Eating Microbes

GEN Edge

Could Single Technologies’ 3D Sequencing Deliver the $10 Genome?

Drug Discovery

StockWatch: MacroGenics Shares Crater after Trial Deaths